H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Neutral rating and $7.00 price target on Kyverna Therapeutics Inc (NASDAQ: KYTX).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE